Detalles de la búsqueda
1.
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations.
Br J Cancer
; 120(1): 57-62, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30377342
2.
Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population.
Oncologist
; 24(11): e1165-e1171, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30996007
3.
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.
BJU Int
; 123(1): 98-105, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29956884
4.
Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program.
Future Oncol
; 14(14): 1347-1354, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29774766
5.
Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program.
Lung Cancer
; 140: 59-64, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31881412
6.
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Sci Rep
; 10(1): 1918, 2020 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32005869
7.
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program.
J Immunother Cancer
; 7(1): 99, 2019 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30944023
8.
Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non-small cell lung cancer.
Eur J Cancer
; 123: 72-80, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31671314
9.
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Sci Rep
; 9(1): 11527, 2019 08 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31395900
10.
Use of nivolumab in elderly patients with advanced squamous non-small-cell lung cancer: results from the Italian cohort of an expanded access programme.
Eur J Cancer
; 100: 126-134, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30014881
11.
Italian Nivolumab Expanded Access Program in Nonsquamous Non-Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients.
J Thorac Oncol
; 13(8): 1146-1155, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29730379
12.
Impact of second-line cetuximab-containing therapy in patients with KRAS wild-type metastatic colorectal cancer: results from the ITACa randomized clinical trial.
Sci Rep
; 7(1): 10426, 2017 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28874797
13.
Bolus fluorouracil and leucovorin with oxaliplatin as first-line treatment in metastatic colorectal cancer.
J Clin Oncol
; 20(10): 2545-50, 2002 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12011134
14.
BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience.
J Thorac Oncol
; 14(3): e57-e59, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30782386
15.
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients.
Sci Rep
; 4: 6828, 2014 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25370899
16.
Ovarian Sertoli-Leydig cell tumor, endometrioid-like yolk sac tumor, and Y-chromosomal material.
Oncology
; 64(4): 370-3, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12759534
Resultados
1 -
16
de 16
1
Próxima >
>>